These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 37120540)
1. Functional genomics in stroke: current and future applications of iPSCs and gene editing to dissect the function of risk variants. Granata A BMC Cardiovasc Disord; 2023 Apr; 23(1):223. PubMed ID: 37120540 [TBL] [Abstract][Full Text] [Related]
2. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association. Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC; Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173 [TBL] [Abstract][Full Text] [Related]
3. RNA-Generated and Gene-Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy. Kehler J; Greco M; Martino V; Pachiappan M; Yokoe H; Chen A; Yang M; Auerbach J; Jessee J; Gotte M; Milanesi L; Albertini A; Bellipanni G; Zucchi I; Reinbold RA; Giordano A J Cell Physiol; 2017 Jun; 232(6):1262-1269. PubMed ID: 27631155 [TBL] [Abstract][Full Text] [Related]
4. Genome editing in pluripotent stem cells: research and therapeutic applications. Deleidi M; Yu C Biochem Biophys Res Commun; 2016 May; 473(3):665-74. PubMed ID: 26930470 [TBL] [Abstract][Full Text] [Related]
5. Gene correction in patient-specific iPSCs for therapy development and disease modeling. Jang YY; Ye Z Hum Genet; 2016 Sep; 135(9):1041-58. PubMed ID: 27256364 [TBL] [Abstract][Full Text] [Related]
6. [Induced pluripotent stem cell technology and its application in disease research]. Cai CY; Meng FL; Rao L; Liu YY; Zhao XL Yi Chuan; 2020 Nov; 42(11):1042-1061. PubMed ID: 33229312 [TBL] [Abstract][Full Text] [Related]
7. Application of induced pluripotent stem cell technology for the investigation of hematological disorders. Dolatshad H; Tatwavedi D; Ahmed D; Tegethoff JF; Boultwood J; Pellagatti A Adv Biol Regul; 2019 Jan; 71():19-33. PubMed ID: 30341008 [TBL] [Abstract][Full Text] [Related]
8. Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders. Wattanapanitch M Stem Cells Int; 2019; 2019():5171032. PubMed ID: 31191673 [TBL] [Abstract][Full Text] [Related]
15. Role of induced pluripotent stem cells in lysosomal storage diseases. Kido J; Nakamura K; Era T Mol Cell Neurosci; 2020 Oct; 108():103540. PubMed ID: 32828964 [TBL] [Abstract][Full Text] [Related]
16. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications. Omole AE; Fakoya AOJ PeerJ; 2018; 6():e4370. PubMed ID: 29770269 [TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cell technology: a decade of progress. Shi Y; Inoue H; Wu JC; Yamanaka S Nat Rev Drug Discov; 2017 Feb; 16(2):115-130. PubMed ID: 27980341 [TBL] [Abstract][Full Text] [Related]
18. Path from schizophrenia genomics to biology: gene regulation and perturbation in neurons derived from induced pluripotent stem cells and genome editing. Duan J Neurosci Bull; 2015 Feb; 31(1):113-27. PubMed ID: 25575480 [TBL] [Abstract][Full Text] [Related]
19. Targeted mutagenesis in human iPSCs using CRISPR genome-editing tools. Long Y; Cech TR Methods; 2021 Jul; 191():44-58. PubMed ID: 33444739 [TBL] [Abstract][Full Text] [Related]
20. CRISPR Base Editing in Induced Pluripotent Stem Cells. Chang YJ; Xu CL; Cui X; Bassuk AG; Mahajan VB; Tsai YT; Tsang SH Methods Mol Biol; 2019; 2045():337-346. PubMed ID: 31250381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]